Raman-active reagents and the use thereof
View Patent ↗The present invention provides a new class of Raman-active reagents for use in biological and other applications, as well as methods and kits for their use and manufacture. Each reagent includes a Raman-active reporter molecule, a binding molecule, and a surface enhancing particle capable of causing surface enhanced Raman scattering (SERS). The Raman-active reporter molecule and the binding molecule are affixed to the particle to give both a strong SERS signal and to provide biological functionality, i.e. antigen or drug recognition. The Raman-active reagents can function as an alternative to fluorescence-labeled reagents, with advantages in detection including signal stability, sensitivity, and the ability to simultaneously detect several biological materials. The Raman-active reagents also have a wide range of applications, especially in clinical fields (e.g., immunoassays, imaging, and drug screening).
1. A Raman-active reagent comprising a non polymeric bi-functional Raman-active reporter molecule monolayer which includes a reactive group, a binding molecule, and a surface enhancing particle capable of causing surface enhanced Raman scattering, the Raman-active bi-functional monolayer reporter molecule being chemically linked to the surface enhancing particle and providing a detectable or measurable Raman scattering signal when illuminated by an excitation source capable of inducing a Raman scattering, the Raman-active reporter molecule operably linked to the binding molecule through the reactive group, wherein the binding molecule is capable of specifically binding to a target analyte, and wherein the Raman-active reporter molecule operably links the binding molecule to the surface enhancing particle to form a Raman-active reagent.
2. The Raman-active reagent of claim 1 wherein the binding molecule is selected from the group of lectins, lectin fragments, lectin derivatives, antigens, monoclonal antibodies, polyclonal antibodies, immunoreactive fragments, immunoreactive derivatives, peptides, haptens, aptamers, nucleic acid molecules, crown ethers, cyclodextrins, cryptands, and calixarenes.
3. The Raman-active reagent of claim 1 wherein the binding molecule is anti-prostate-specific antigen (anti-PSA).
4. The Raman-active reagent of claim 1 wherein the Raman-active reporter molecule is selected from the group consisting of dithiobisbenzonic acid, 4-mercaptobenzoic acid, 4,4′-dithiobis(succinimidylbenzoate), direct red 81, Chicago sky blue, p-dimethylaminoazobenzene, 4-(4-Aminophenylazo)phenylarsonic acid monosodium salt, 1,5-difluoro-2,4-dinitrobenzene, arsenazo I, basic fuchsin, disperse orange 3, HABA (2-(4-hydroxyphenylazo)-benzoic acid, erythrosine B, trypan blue, ponceau S, ponceau SS, 5,5′-dithiobis(2-nitrobenzoic acid), metal complexes and polymeric particles.
5. The Raman-active reagent of claim 1 wherein the reactive group is a terminal functional group of a reactive compound that is selected from the group consisting of succinimides, maleimides, isothiocyanates, isocyanates, acyl azides, sulfonyl chlorides, aldehydes, glyoxals, epoxides, oxiranes carbodiimides, carbonates, arylating agents, acryloyl derivatives, diazoalkanes, diazoacetyl compounds, anhydrides, aziridines, imidoesters, or carbonyldiimidazole.
6. The Raman-active reagent of claim 1 wherein the reactive group is a terminal succinimide group of the reactive compound N-hydroxysuccinimide (NHS).
7. The Raman-active reagent of claim 1 wherein the surface enhancing particle comprises a metallic material.
8. The Raman-active reagent of claim 7 wherein the metallic material is either gold, silver, copper, platinum, aluminum, gallium, indium, zinc or cadmium.
9. The Raman-active reagent of claim 8 wherein the metallic material is gold.
10. The Raman-active reagent of claim 1 wherein the surface enhancing particle is either a silica, plastic, glass, carbon, ceramic or magnetic material, coated with a metallic material.
11. A Raman-active reagent comprising a Raman-active reporter molecule which includes a reactive group, a binding molecule, and a surface enhancing particle being a colloidal gold particle capable of causing surface enhanced Raman scattering, the Raman-active reporter molecule being 5,5′-disthiobis(succinimidyl-2-nitrobenzoate) linked to the surface enhancing particle by a thiol linkage and providing a detectable or measurable Raman scattering signal when illuminated by an excitation source capable of inducing a Raman scattering, the reactive group being the succinimide of the disthiobis(succinimidyl-2-nitrobenzoate), and wherein binding molecule is an antibody capable of specifically binding to a target analyte.
12. A kit for determining the presence or amount of a target analyte in a test sample, the kit comprising:
(a) a Raman-active reagent including a bi-functional non polymeric Raman-active reporter molecule monolayer which includes a reactive group, a binding molecule, and a surface enhancing particle capable of causing surface enhanced Raman scattering, the Raman-active reporter molecule being chemically linked to the surface enhancing particle and providing a detectable or measurable Raman scattering signal when illuminated by an excitation source capable of inducing a Raman scattering, the Raman-active reporter molecule operably linked to the binding molecule through the reactive group, and wherein the Raman-active reporter molecule operably links the binding molecule, capable of specifically binding a target analyte, to the surface enhancing particle to form a reagent/analyte complex; and
(b) a substrate capable of binding the target analyte or the reagent/analyte complex prior to inducing Raman scattering with the excitation source.
13. The kit of claim 12 wherein the binding molecule is selected from the group of lectins, lectin fragments, lectin derivatives, antigens, monoclonal antibodies, polyclonal antibodies, immunoreactive fragments, immunoreactive derivatives, peptides, haptens, aptamers, nuclei(original) c acid molecules, crown ethers, cyclodextrins, cryptands, and calixarenes.
14. The kit of claim 12 wherein the binding molecule is anti-prostate-specific antigen (anti-PSA).
15. The kit of claim 12 wherein the Raman-active reporter molecule is selected from the group consisting of dithiobisbenzonic acid, 4-mercaptobenzoic acid, 4,4′-dithiobis(succinimidylbenzoate), direct red 81, Chicago sky blue, p-dimethylaminoazobenzene, 4-(4-Aminophenylazo)phenylarsonic acid monosodium salt, 1,5-difluoro-2,4-dinitrobenzene, arsenazo I, basic fuchsin, disperse orange 3, HABA (2-(4-hydroxyphenylazo)-benzoic acid, erythrosine B, trypan blue, ponceau S, ponceau SS, 5,5′-dithiobis(2-nitrobenzoic acid), metal complexes and polymeric particles.
16. The kit of claim 12 wherein the reactive group is terminal functional group of a reactive compound that is selected from the group consisting of succinimides, maleimides, isothiocyanates, isocyanates, acyl azides, sulfonyl chlorides, aldehydes, glyoxals, epoxides, oxiranes carbodiimides, carbonates, arylating agents, acryloyl derivatives, diazoalkanes, diazoacetyl compounds, anhydrides, aziridines, imidoesters, or carbonyldiimidazole.
17. The kit of claim 12 wherein the reactive group is a terminal succinimide group of the reactive compound N-hydroxysuccinimide (NHS).
18. The kit of claim 12 wherein the surface enhancing particle comprises a metallic material.
19. The kit of claim 18 wherein the metallic material is either gold, silver, copper, platinum, aluminum, gallium, indium, zinc or cadmium.
20. The kit of claim 19 wherein the metallic material is gold.
21. The kit of claim 12 wherein the surface enhancing particle is either a silica, plastic, glass, carbon, ceramic or magnetic material, coated with a metallic material.
22. The kit of claim 21 wherein the metallic material is either gold, silver, copper, platinum, aluminum, gallium, indium, zinc or cadmium.
23. The kit of claim 22 wherein the metallic material is gold.